Table 4.
Sample no. | Age | Sex | Cobas | Daan | Duplex-S | Duplex-C |
---|---|---|---|---|---|---|
302-1 | 6 | F | 65.2 | No | 694 | 188 |
302-17 | 45 | F | 31.2 | No | 414 | 310.2 |
302-44 | 25 | M | 991 | No | 15010 | 15470 |
302-45 | 1 | F | 3.06E7 | No | 4.17E8 | 1.83E8 |
302-66 | 26 | M | 2.00E6 | No | 2.32E7 | 1.90E7 |
302-68 | 40 | M | 5.06E5 | No | 6.68E6 | 9.07E6 |
302-74 | 65 | F | 28.3 | No | 286 | 62.58 |
302-76 | 51 | M | 1.24E5 | No | 5.47E6 | 3.74E6 |
302-80 | 52 | M | 1.10E6 | No | 2.00E7 | 3.76E6 |
302-91 | 20 | M | 124 | No | 5437 | 488 |
302-102 | 45 | M | 81.9 | No | 2470 | 165 |
Chaoyang-9 | 62 | F | No | 6.14E4 | 1.35E6 | 1.01E6 |
Chaoyang-36 | 82 | M | No | 2.76E3 | 6.32E4 | 8.46E3 |
Chaoyang-53 | 26 | F | No | 2.24E3 | 5.83E4 | 1.93E4 |
*Only patients whose HBV DNA quantitative results from the duplex real-time PCR were at least 1.0 log10 higher than that using Roche kit or Daan kit are listed. (Unit: IU/ml)